The two-day MoneyShow just wrapped up in Toronto after running from Friday (September 14) to Saturday (September 15).

The Investing News Network (INN) team attended day two of the MoneyShow and kept busy attending presentations and panel discussions during the Cannabis Investing Event portion of the conference.


Below we’ve put together some highlights from the conference. Scroll on to read more about what happened on the show floor and stay tuned for more in-depth articles on the various cannabis panels.

MoneyShow Toronto

During the morning portion of the conference, Anthony Dutton, CEO, co-founder and director at Cannex Capital Holdings (CSE:CNNX), hosted a panel called Developing a High-value Portfolio of Multi-state Assets in the Cannabis Industry. Additionally, Steven Hawkins, president and CEO of Horizons ETFs, provided a general cannabis outlook for the public markets.

Despite his expertise and close eye on the cannabis market, Hawkins is unsure of the future after legalization in Canada. “We really do not know what will happen on October 17,” he said.

Hawkins added that although he doesn’t know how the market will shape up, it is sure to be different.

For the remainder of the panel, Hawkins discussed a variety of important sales and acquisitions within the Canadian cannabis industry. Horizons has benefited from the rapid rise of the market with the launch of two ETFs dedicated to following the industry.

“HMMJ’s growth has far exceeded our expectations as investors have strongly supported the sector in anticipation of Canada’s upcoming recreational marijuana legalization,” Hawkins said after the ETF crossed the C$1-billion mark.

The afternoon portion of the conference consisted of two important panel discussions that covered the Canadian cannabis industry.

Both the first panel, How Green is Green? Outlook on the Canadian Cannabis Market, and the second panel, Cannabis in Canada: What Investors Need to Know About the Changing Legal Landscape, were moderated by Jay Rosenthal, co-founder and president of Business of Cannabis, a research and media company focused on the cannabis market.

The first panel of the afternoon included:

  • Cam Battley, CCO of Aurora Cannabis (TSX:ACB,OTCQB:ACBFF)
  • Danny Brody, vice president, investor relations, at the Green Organic Dutchman Holdings (TSX:TGOD,OTCQX:TGODF)
  • Mark Noble, senior vice president, ETF strategy, at Horizons ETFs
  • Chris Wagner, CEO of Emerald Health Therapeutics (TSX:EMH,OTCQX:EMHTF)

After discussing how the cannabis industry may change following legalization, the panel went on to discuss the importance of cannabis being available to consumers in a multitude of forms.

The panel ended with a warning from Battley. He noted that there are far too many cannabis companies and said many of them will be weeded out in the next few years.

The final panel of the conference included:

  • Greg Engel, CEO of Organigram Holdings (TSXV:OGI,OTCQX:OGRMF)
  • Jessica Martin, vice president, public relations, at Invictus MD (TSXV:GENE,OTC:IVITF)
  • George Robinson, CEO of RavenQuest BioMed (CSE:RQB)

Don’t forget to follow us @INN_Cannabis for real-time news updates and stay tuned for more cannabis stories from the MoneyShow!

Securities Disclosure: I, Nicole Rashotte, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Invictus MD is a client of the Investing News Network. This article is not paid-for content.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

Keep reading... Show less